The role of myelin damage in Alzheimer’s disease pathology

por Papuć, Ewa, Rejdak, Konrad
Publicado 2018

Increased CSF NFL in Non-demented Parkinson’s Disease Subjects Reflects Early White Matter Damage

por Papuć, Ewa, Rejdak, Konrad
Publicado 2020

Increased Cerebrospinal Fluid S100B and NSE Reflect Neuronal and Glial Damage in Parkinson’s Disease

por Papuć, Ewa, Rejdak, Konrad
Publicado 2020

Humoral Response against Small Heat Shock Proteins in Parkinson’s Disease

por Papuć, Ewa, Kurys-Denis, Ewa, Krupski, Witold, Rejdak, Konrad
Publicado 2015

Antibodies against small heat-shock proteins in Alzheimer’s disease as a part of natural human immune repertoire or activation of humoral response?

por Papuć, Ewa, Krupski, Witold, Kurys-Denis, Ewa, Rejdak, Konrad
Publicado 2015

Decreased Cerebrospinal Fluid Orexin-A (Hypocretin-1) Concentrations in Patients after Generalized Convulsive Status Epilepticus

por Samzadeh, Mojdeh, Papuć, Ewa, Furtak-Niczyporuk, Marzena, Rejdak, Konrad
Publicado 2020

NMOSD—Diagnostic Dilemmas Leading towards Final Diagnosis

por Szewczyk, Anna K., Papuć, Ewa, Mitosek-Szewczyk, Krystyna, Woś, Michał, Rejdak, Konrad
Publicado 2022

The Usefulness of Optical Coherence Tomography in Disease Progression Monitoring in Younger Patients with Relapsing-Remitting Multiple Sclerosis: A Single-Centre Study

por Torbus, Magdalena, Niewiadomska, Ewa, Dobrakowski, Paweł, Papuć, Ewa, Rybus-Kalinowska, Barbara, Szlacheta, Patryk, Korzonek-Szlacheta, Ilona, Kubicka-Bączyk, Katarzyna, Łabuz-Roszak, Beata
Publicado 2022

The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV-PREVENT): Study rationale and design

por Rejdak, Konrad, Fiedor, Piotr, Bonek, Robert, Goch, Aleksander, Gala-Błądzińska, Agnieszka, Chełstowski, Waldemar, Łukasiak, Jacek, Kiciak, Sławomir, Dąbrowski, Piotr, Dec, Mateusz, Król, Zbigniew J., Papuć, Ewa, Zasybska, Adriana, Segiet, Agnieszka, Grieb, Paweł
Publicado 2022